Latest filing published 18 Jul 2025 for Aurinia Pharmaceuticals Inc., €329k. Read the official filing
This profile gathers the share dealings of Aurinia Pharmaceuticals in Aurinia Pharmaceuticals Inc. Between 13 January 2025 and 15 July 2025, the trades on record add up to 125 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 18 July 2025, reports a transaction of €329k in Aurinia Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 74 declarations